Home About us Editorial board Current issue Ahead of print Archives Submit article Instructions Subscribe Login  Contact Search

 
ERRATUM
Ahead of print publication  

Erratum: efficacy and safety of hepano tablet in liver disorder patients with abnormal liver function test: A randomized active controlled prospective clinical study


Correspondence Address:
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/2394-6555.223450



How to cite this URL:
. Erratum: efficacy and safety of hepano tablet in liver disorder patients with abnormal liver function test: A randomized active controlled prospective clinical study. Drug Dev Ther [Epub ahead of print] [cited 2018 Dec 18]. Available from: http://www.ddtjournal.org/preprintarticle.asp?id=223450

In the article titled, "Efficacy and safety of hepano tablet in liver disorder patients with abnormal liver function test: A randomized active controlled prospective clinical study" published on pages 6-12, Issue 1, Volume 8 of Drug Development and Therapeutics,[1] [Figure 4] has been incorrectly published. The figure legends and numbers are correct. The correct [Figure 4] is as below.



 
  References Top

1.
Efficacy and safety of hepano tablet in liver disorder patients with abnormal liver function test: A randomized active controlled prospective clinical study. Drug Dev Ther 2017;8:6-12.  Back to cited text no. 1
    


    Figures

  [Figure 4]



 

 
Top
 
 
  Search
 
   
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
References
Article Figures

 Article Access Statistics
    Viewed520    
    PDF Downloaded43    

Recommend this journal